Treatment of symptomatic pulmonary aspergillomas with intracavitary instillation of amphotericin B through an indwelling catheter.
BACKGROUND
The treatment of symptomatic pulmonary aspergillomas can be difficult. One approach has been to deliver antifungal drugs directly into the lung cavity. The use of this method of treatment is described in which an indwelling percutaneous catheter is used which avoids repeated needlings of the cavity and may allow extended treatment on a domiciliary basis.


METHODS
Amphotericin B was delivered through indwelling percutaneous intracavitary catheters to treat five symptomatic episodes in four patients with pulmonary aspergillomas.


RESULTS
The treatment was well tolerated by all patients and their symptoms resolved in four of the five episodes. Two patients died, one from an unrelated bronchopneumonia and the other from advanced cachexia. Two patients remain symptom free after eight and 12 months.


CONCLUSIONS
Intracavitary administration of amphotericin through an indwelling catheter should be considered for any patient who has troublesome sputum production, haemoptysis, or systemic symptoms attributable to an aspergilloma.
Jackson
M
M
Department of Respiratory Medicine, Papworth Hospital, Papworth Everard, Cambs.
Flower
C D
CD
Shneerson
J M
JM
D000328:Adult; D000368:Aged; D000666:Amphotericin B / Q000008:administration & dosage*; D001229:Aspergillosis, Allergic Bronchopulmonary / Q000188:drug therapy*; D002408:Catheters, Indwelling; D006801:Humans; D008297:Male; D008875:Middle Aged
D000666:Amphotericin B